Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Sign in
Join now
Anne Valente MD
Anne Marie Valente MD Advisory Board
Benjamin Scirica MD
Benjamin Morgan Scirica MD Associate Editor
J. William McEvoy MB BCh BAO, MEd, MHS, PhD, FRCPI
J. William McEvoy MB BCh BAO, MEd, MHS, PhD, FRCPI Advisory Board
See All Experts
featured
Published in Cardiology

Expert Opinion / Commentary · November 13, 2017

2017 Top Stories in Cardiology: The COMPASS Trial

Deepak Bhatt MD, MPH, FACC, FAHA, FESC, MSCAI

 

 Save  Recommend
 Share

Additional Info

  1. Eikelboom JW, Connolly SJ, Bosch J, et al. Rivaroxaban With or Without Aspirin in Stable Cardiovascular Disease. N Engl J Med. 2017;377(14):1319-1330.

Disclosure statements are available on the authors' profiles:

Deepak Bhatt MD, MPH, FACC, FAHA, FESC, MSCAI

Further Reading

Most Read This Week

Recently Updated